5HTTLPR Genetic Variant and Major Depressive Disorder: A Review
- PMID: 33114535
- PMCID: PMC7692865
- DOI: 10.3390/genes11111260
5HTTLPR Genetic Variant and Major Depressive Disorder: A Review
Abstract
Major Depressive Disorder (MDD) is a disease that involves biological, psychological, and social interactions. Studies have shown the importance of genetics contribution to MDD development. The SCL6A4 protein (5HTTLPR) functions transporting serotonin, a neurotransmitter linked to mood and emotion, to the synaptic cleft. Hence, this study seeks, through a literature review, a better comprehension of the 5HTTLPR genetic variant association with MDD. For this purpose, a search was performed on the Virtual Health Library Portal for articles that related 5HTTLPR to MDD. Most of the articles found were conducted in the American continent, with one (1) study implemented in Brazil. 5HTTLPR associations were found regarding changes in the nervous system, pharmacology, and risk factors seen in MDD patients. When verifying the allelic distribution, the S allele had a higher frequency in most of the studies analyzed. Despite not finding a commonality in the different studies, the tremendous genetic variation found demonstrates the MDD complexity. For this reason, further studies in diverse populations should be conducted to assist in the understanding and treatment of the disease.
Keywords: 5HTTLPR; genetic polymorphism; major depressive disorder; nervous system; pharmacogenomics; risk-factors.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
References
-
- World Health Organization . World Heal Organization; 2017. [(accessed on 1 October 2020)]. Depression and Other Common Mental Disorders: Global Health Estimates. Available online: https://apps.who.int/iris/bitstream/handle/10665/254610/WHO-MSD-MER-2017....
-
- Ferrari A.J., Charlson F.J., Norman R.E., Patten S.B., Freedman G.D., Murray C.J., Vos T., Whiteford H.A. Burden of Depressive Disorders by Country, Sex, Age, and Year: Findings from the Global Burden of Disease Study 2010. PLoS Med. 2013;10:e1001547. doi: 10.1371/journal.pmed.1001547. - DOI - PMC - PubMed
-
- Wang H., Naghavi M., Allen C., Barber R.M., Bhutta Z.A., Carter A., Casey D.C., Charlson F.J., Chen A.Z., Coates M.M., et al. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: A systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016;388:1459–1544. doi: 10.1016/S0140-6736(16)31012-1. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
